Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)

Paul J. Hengeveld; Y. Emre Ertem; Julie M. N. Dubois; Clemens H. M. Mellink; Anne-Marie van der Kevie-kersemaekers; Ludo M. Evers; Kim Heezen; P. Martijn Kolijn; Olaf R. F. Mook; M. Mahdi Motazacker; Kazem Nasserinejad; S. Kersting; Peter E. Westerweel; Carsten U. Niemann; Arnon P. Kater; Anton W. Langerak; Mark-David Levin

doi:10.1038/s41375-022-01600-6

Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)

Paul J. Hengeveld, Y. Emre Ertem, Julie M. N. Dubois, Clemens H. M. Mellink, Anne-Marie van der Kevie-kersemaekers, Ludo M. Evers, Kim Heezen, P. Martijn Kolijn, Olaf R. F. Mook, M. Mahdi Motazacker, Kazem Nasserinejad, S. Kersting, Peter E. Westerweel, Carsten U. Niemann, Arnon P. Kater, Anton W. Langerak, Mark-David Levin^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Letter › peer review

5 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia
Vol/bind	36
Udgave nummer	7
Sider (fra-til)	1935-1938
Antal sider	4
ISSN	0887-6924
DOI	https://doi.org/10.1038/s41375-022-01600-6
Status	Udgivet - 2022

Adgang til dokumentet

10.1038/s41375-022-01600-6

Citationsformater

Hengeveld, P. J., Ertem, Y. E., Dubois, J. M. N., Mellink, C. H. M., van der Kevie-kersemaekers, A.-M., Evers, L. M., Heezen, K., Kolijn, P. M., Mook, O. R. F., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P. E., Niemann, C. U., Kater, A. P., Langerak, A. W., & Levin, M.-D. (2022). Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110). Leukemia, 36(7), 1935-1938. https://doi.org/10.1038/s41375-022-01600-6

Hengeveld, PJ, Ertem, YE, Dubois, JMN, Mellink, CHM, van der Kevie-kersemaekers, A-M, Evers, LM, Heezen, K, Kolijn, PM, Mook, ORF, Motazacker, MM, Nasserinejad, K, Kersting, S, Westerweel, PE, Niemann, CU, Kater, AP, Langerak, AW & Levin, M-D 2022, 'Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)', Leukemia, bind 36, nr. 7, s. 1935-1938. https://doi.org/10.1038/s41375-022-01600-6

@article{3f14e97c4bc747d89285b9ac2e1efc76,

title = "Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)",

keywords = "SUBSETS, CLL",

author = "Hengeveld, {Paul J.} and Ertem, {Y. Emre} and Dubois, {Julie M. N.} and Mellink, {Clemens H. M.} and {van der Kevie-kersemaekers}, Anne-Marie and Evers, {Ludo M.} and Kim Heezen and Kolijn, {P. Martijn} and Mook, {Olaf R. F.} and Motazacker, {M. Mahdi} and Kazem Nasserinejad and S. Kersting and Westerweel, {Peter E.} and Niemann, {Carsten U.} and Kater, {Arnon P.} and Langerak, {Anton W.} and Mark-David Levin",

year = "2022",

doi = "10.1038/s41375-022-01600-6",

language = "English",

volume = "36",

pages = "1935--1938",

journal = "Leukemia",

issn = "0887-6924",

publisher = "nature publishing group",

number = "7",

}

TY - JOUR

T1 - Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)

AU - Hengeveld, Paul J.

AU - Ertem, Y. Emre

AU - Dubois, Julie M. N.

AU - Mellink, Clemens H. M.

AU - van der Kevie-kersemaekers, Anne-Marie

AU - Evers, Ludo M.

AU - Heezen, Kim

AU - Kolijn, P. Martijn

AU - Mook, Olaf R. F.

AU - Motazacker, M. Mahdi

AU - Nasserinejad, Kazem

AU - Kersting, S.

AU - Westerweel, Peter E.

AU - Niemann, Carsten U.

AU - Kater, Arnon P.

AU - Langerak, Anton W.

AU - Levin, Mark-David

PY - 2022

Y1 - 2022

KW - SUBSETS

KW - CLL

U2 - 10.1038/s41375-022-01600-6

DO - 10.1038/s41375-022-01600-6

M3 - Letter

C2 - 35585140

SN - 0887-6924

VL - 36

SP - 1935

EP - 1938

JO - Leukemia

JF - Leukemia

IS - 7

ER -